No association between α1-antichymotrypsin and apolipoprotein e in Alzheimer's disease and vascular dementia

Alzheimer's Reports

Volumn 2, Issue 3, 1999, Pages 159-164

  Durany, Nuria ^a   Cruz Sánchez, Felix F ^a   Thome, Johannes ^a   Höhn, Holger ^a   Retz, Wolfgang ^a   Riederer, Peter ^a   Rosier, Michael ^a  

^a UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002958829     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Arai H (1996). Biological markers for the clinical diagnosis of Alzheimer's disease. Tohoku J Exp Med 179, 65-79.
2. Dilling H, Mombour W and Schmidt MH (1991). Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F) Klinisch-diagnostische Leitlinien. Weltgesundheitorganisation (WHO). Huber, Göttingen.
3. 1-antichymotrypsin microsatellite and apolipoprotein E in Alzheimer's disease. Alz Rep 1, 315-320.
4. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. J Hepatol 18, 313-321.
5. Frisoni GB, Calabresi L, Geroldi C et al. (1994). Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 5, 240-242.
6. Haines JL, Pritchard ML, Saunders AM et al. (1996). No genetic effect of α-1-antichymotrypsin in Alzheimer Disease. Genomics 33, 53-56.
7. Helisalmi S, Mannerna A, Lehtovirta M et al. (1997). No association between α1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease. Neurosci Lett 231, 56-58.
8. Ji Y, Urakami K, Adachi Y et al. (1998). Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 9, 243-245.
9. 1-antichymotrypsin polymorphism. Nature Genet 10, 486-488.
10. Kawamata J, Tanaka S, Shimohama S et al. (1994). Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psych 57, 1414-1416.
11. Ma J, Yee A, Brewer HB et al. (1994). Amyloid-associated proteins α-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
12. Ma J, Brewer Band Potter H (1996). Alzheimer Aβ neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides. Neurobiol Aging 17, 773-780.
13. McKhann G, Drachmann D and Folstein M (1994). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspicies of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944.
14. Müller U, Bödeker R-H, Gerundt I et al. (1996). Lack of association α1-antichymotrypsin polymorphism; Alzheimer's disease and allele ε4 of apolipoprotein E. Neurology 47, 1575-1577
15. Muramatsu T, Matsushita S, Aral H et al. (1996). α1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J Neural Transm 103, 1205-1210.
16. Nacmias B, Tedde A, Latorraca S et al. (1996). Apolipoprotein E and α1-antichymotrypsin polymorphism in Alzheimer's disease. Ann Neurol 40, 678-680.
17. Palumbo B, Parnetii L, Nocentini G et al. (1997) Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's diesease and vascular dementia patients. Neurosci Lett 231, 50-61.
18. Patt S, Prinz M, Mitrovics T and Cervós Navarro J (1995). Neuropathological diagnostic criteria for vascular dementia. In: F.F. Cruz-Sánchez (ed.) Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam: pp 55-64.
19. Román GC, Tatemichi TK, Erkinjuntti T et al. (1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
20. Roses AD (1996). Apolipoprotein E alleles as risk factors in Alzheimer's disease. Ann Rev Med 47, 387-400.
21. Scacchi R, De Bemardini L, Mantuano E et al. (1995). Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett 201, 231-234.
22. Stengard JH, Pekkanen J, Sulkava R et al. (1995). Apolipoprotein E polymorphism, Alzheimers's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 92, 297-298.
23. Talbot C, Houlden H, Craddock N et al. (1995). Polymorphism in AACT gene may lower age of onset of AD. NeuroReport 7, 534-536.
24. Thome J, Baumer A, Kornhuber J et al. (1995) Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E-tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J Neural Transm 10, 207-212.
25. Travis J, Gamer D and Bowen J (1978). Human α1-antichymotrypsin: purification and properties. Biochemistry 17, 5647-5651.
26. Traves TA, Bornstein NM, Chapman J et al. (1996) APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia. Alz Dis Assoc Disord 10, 189-191.
27. Weisgraber K.H, Pitas RE and Mahley RW (1994). Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr Opin Struct Biol 4, 507-515.
28. World Medical Association 1989 Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects (Amended by the 41st World Medical Assembly, Hong Kong, September, 1989).
29. Yoshiiwa A, Kamino K, Yamamoto H et al. (1997). α 1-antichymotrypsin as a risk modifier for late-onset Alzheimer Disease in Japanese apolippoprotein E ε4 allele carriers. Ann Neurol 42, 115-117.